BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 14657716)

  • 1. Molecular evidence of anaplastic transformation in coexisting well-differentiated and anaplastic carcinomas of the thyroid.
    Hunt JL; Tometsko M; LiVolsi VA; Swalsky P; Finkelstein SD; Barnes EL
    Am J Surg Pathol; 2003 Dec; 27(12):1559-64. PubMed ID: 14657716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of a hobnail pattern in papillary, poorly differentiated, and anaplastic thyroid carcinoma: a possible manifestation of high-grade transformation.
    Amacher AM; Goyal B; Lewis JS; El-Mofty SK; Chernock RD
    Am J Surg Pathol; 2015 Feb; 39(2):260-5. PubMed ID: 25321328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation.
    Oishi N; Kondo T; Ebina A; Sato Y; Akaishi J; Hino R; Yamamoto N; Mochizuki K; Nakazawa T; Yokomichi H; Ito K; Ishikawa Y; Katoh R
    Mod Pathol; 2017 Nov; 30(11):1527-1537. PubMed ID: 28731042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas.
    Nikiforov YE
    Endocr Pathol; 2004; 15(4):319-27. PubMed ID: 15681856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
    Nikiforova MN; Kimura ET; Gandhi M; Biddinger PW; Knauf JA; Basolo F; Zhu Z; Giannini R; Salvatore G; Fusco A; Santoro M; Fagin JA; Nikiforov YE
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5399-404. PubMed ID: 14602780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic thyroid cancer evolved from papillary carcinoma: demonstration of anaplastic transformation by means of the inter-simple sequence repeat polymerase chain reaction.
    Wiseman SM; Loree TR; Hicks WL; Rigual NR; Winston JS; Tan D; Anderson GR; Stoler DL
    Arch Otolaryngol Head Neck Surg; 2003 Jan; 129(1):96-100. PubMed ID: 12525202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment.
    Begum S; Rosenbaum E; Henrique R; Cohen Y; Sidransky D; Westra WH
    Mod Pathol; 2004 Nov; 17(11):1359-63. PubMed ID: 15195111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.
    Nakamura T; Yana I; Kobayashi T; Shin E; Karakawa K; Fujita S; Miya A; Mori T; Nishisho I; Takai S
    Jpn J Cancer Res; 1992 Dec; 83(12):1293-8. PubMed ID: 1483945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
    Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
    Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
    Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
    Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
    Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P63 expression in papillary and anaplastic carcinomas of the thyroid gland: lack of an oncogenetic role in tumorigenesis and progression.
    Preto A; Reis-Filho JS; Ricardo S; Soares P
    Pathol Res Pract; 2002; 198(7):449-54. PubMed ID: 12234063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
    Takano T; Ito Y; Hirokawa M; Yoshida H; Miyauchi A
    Br J Cancer; 2007 May; 96(10):1549-53. PubMed ID: 17453004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of survivin in thyroid tumors: differences of expression in well-differentiated, non-well-differentiated, and anaplastic thyroid cancers.
    Pannone G; Santoro A; Pasquali D; Zamparese R; Mattoni M; Russo G; Landriscina M; Piscazzi A; Toti P; Cignarelli M; Lo Muzio L; Bufo P
    Thyroid; 2014 Mar; 24(3):511-9. PubMed ID: 24117205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 7-cM region of frequent allelic loss on chromosome band 16p13.3 that is specifically associated with anaplastic thyroid carcinoma.
    Kadota M; Tamaki Y; Sakita I; Komoike Y; Miyazaki M; Ooka M; Masuda N; Fujiwara Y; Ohnishi T; Tomita N; Sekimoto M; Ohue M; Ikeda T; Kobayashi T; Horii A; Monden M
    Oncol Rep; 2000; 7(3):529-33. PubMed ID: 10767363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas.
    Fagin JA; Matsuo K; Karmakar A; Chen DL; Tang SH; Koeffler HP
    J Clin Invest; 1993 Jan; 91(1):179-84. PubMed ID: 8423216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear DNA in anaplastic thyroid carcinoma with a differentiated component.
    Galera-Davidson H; Bibbo M; Dytch HE; González-Cámpora R; Fernández A; Wied GL
    Histopathology; 1987 Jul; 11(7):715-22. PubMed ID: 3623435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MET receptor tyrosine kinase sequence alterations in differentiated thyroid carcinoma.
    Wasenius VM; Hemmer S; Karjalainen-Lindsberg ML; Nupponen NN; Franssila K; Joensuu H
    Am J Surg Pathol; 2005 Apr; 29(4):544-9. PubMed ID: 15767811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.